BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34318324)

  • 21. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study.
    Jo YY; Yu J; Song KJ; Jang JY; Yoo YJ; Kim SB; Park SR; Kim YH; Kim HR; Kim JH
    Radiother Oncol; 2021 Sep; 162():112-118. PubMed ID: 34265356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
    Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
    Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis.
    van der Wilk BJ; Eyck BM; Hofstetter WL; Ajani JA; Piessen G; Castoro C; Alfieri R; Kim JH; Kim SB; Furlong H; Walsh TN; Nieboer D; Wijnhoven BPL; Lagarde SM; Lanschot JJBV
    Ann Surg; 2022 Mar; 275(3):467-476. PubMed ID: 34191461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes.
    Asombang AW; Chishinga N; Nkhoma A; Chipaila J; Nsokolo B; Manda-Mapalo M; Montiero JFG; Banda L; Dua KS
    World J Gastroenterol; 2019 Aug; 25(31):4512-4533. PubMed ID: 31496629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
    Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
    World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Clinical T1N0M0 Esophageal Cancer.
    Yang AJ; Choi SH; Byun HK; Kim HJ; Choi J; Lee YC; Lee SK; Park KR; Lee CG
    Gut Liver; 2019 May; 13(3):315-324. PubMed ID: 30600672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
    Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage esophagectomy after definitive chemoradiotherapy for synchronous double cancers of the esophagus and head-and-neck.
    Yoshida R; Morita M; Ando K; Masuda T; Saeki H; Oki E; Sadanaga N; Nakashima T; Kakeji Y; Maehara Y
    Dis Esophagus; 2010 Jan; 23(1):59-63. PubMed ID: 19392844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study.
    Klevebro F; Nilsson K; Lindblad M; Ekman S; Johansson J; Lundell L; Ndegwa N; Hedberg J; Nilsson M
    Dis Esophagus; 2020 May; 33(5):. PubMed ID: 31676895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Watanabe M; Mine S; Yamada K; Shigaki H; Baba Y; Yoshida N; Kajiyama K; Yamamoto N; Sano T; Baba H
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):685-92. PubMed ID: 24965711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
    Tie H; He F; Shen J; Zhang B; Ye M; Chen B; Wu Q
    Dis Esophagus; 2018 Jan; 31(1):1-9. PubMed ID: 29087451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
    de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
    Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High versus standard radiation dose of definitive concurrent chemoradiotherapy for esophageal cancer: A systematic review and meta-analysis of randomized clinical trials.
    Wang X; Bai H; Li R; Wang L; Zhang W; Liang J; Yuan Z
    Radiother Oncol; 2023 Mar; 180():109463. PubMed ID: 36642387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic analysis of salvage esophagectomy after definitive chemoradiotherapy for esophageal squamous cell carcinoma: the importance of lymphadenectomy.
    Wang S; Tachimori Y; Hokamura N; Igaki H; Nakazato H; Kishino T
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1805-11. PubMed ID: 24521950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.
    Luo H; Cui YY; Zhang JG; Sun YN; Zheng XL; Yang CL; Ye K; Ge H
    Clin Transl Oncol; 2018 Jul; 20(7):889-898. PubMed ID: 29143229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal nightmare: cancer recurrence after definitive chemoradiation. Is salvage esophagectomy possible?
    Rice TW
    Semin Thorac Cardiovasc Surg; 2013; 25(2):83-6. PubMed ID: 24216522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998.
    Wilson KS; Wilson AG; Dewar GJ
    Can J Gastroenterol; 2002 Jun; 16(6):361-8. PubMed ID: 12096299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.